Janelle F. Ruisinger

Janelle Ruisinger
  • Director - PGY-1 Community-Based Pharmacy Residency (Balls Foods)
  • Clinical Professor
  • Department of Pharmacy Practice

Contact Info

School of Pharmacy, Room 3045-B
2010 Becker Drive
Lawrence, KS 66047-1620


Clinical Professor Janelle F. Ruisinger serves as the Director of the KU Community Pharmacy Residency Program. She is also a Clinical Pharmacist in the KU Medical Center Atherosclerosis and LDL-Apheresis Center which serves as her practice site and primary source for her practice based research.


PGY1 Residency (emphasis on Community Care), The Ohio State University College of Pharmacy, Columbus, OH
Pharm.D., The University of Kansas School of Pharmacy, Lawrence, KS


Courses Taught

  • Pharmaceutical Care Fundamentals – coordinator and instructor
  • Pharmacotherapy II - instructor
  • Chemical Dependency elective – co-coordinator
  • Medical Terminology elective – co-coordinator
  • Immunization Theory and Practice – instructor


  • Preceptor for APPE ambulatory care rotation – The KUMC Atherosclerosis and LDL-Apheresis Center
  • Preceptor for 2 community residents in the University of Kansas School of Pharmacy/Balls Food Stores Community Residency Program

Selected Publications

  • Moriarty PM, Backes JM, Ruisinger JF, Schmelzle K, He J, Dutton JA. “Apple Pectin for the Reduction of Niacin-Induced Flushing”. Journal of Clinical Lipidology in press
  • Backes JM, Gibson CA, Ruisinger JF, Moriarty PM. “The High-Dose Rosuvastatin Once Weekly Study (HD-ROWS)”. Journal of Clinical Lipidology 2012; 6:362-367
  • Brna SA, Ruisinger JF, Howard PA, Barnes BJ, Hare SE,  Study of nonparticipation in an employee diabetes program J Am Pharm Assoc. 2012;52:e105-e108
  • Dodson SE, Ruisinger JF, Howard PA, Hare SE, Barnes BJ. Community pharmacy-based medication therapy management services: financial impact for patients. Pharmacy Practice (Internet) 2012 Jul-Sep;10(3):119-124.
  • Backes JM, Gibson CA, Ruisinger JF, Moriarty PM. Modified-Policosanol Does Not Reduce Plasma Lipoproteins in Hyperlipidemic Patients when Used Alone or in Combination with Statin Therapy.  Lipids 2011 Oct;46(10):923-9
  • Ruisinger JF, Koerner JM, Backes JM, Moriarty PM. Supratherapeutic Response to Ezetimibe in a Statin Intolerant Patient. Hospital Pharmacy 2010;45:45-48

Selected Presentations

  • Schuessler B, Ruisinger JF, Grauer, DW, Moriarty PM, Backes JM. “Comparison of vitamin D dosing regimens in non-obese and obese patients with low vitamin d levels”. The American College of Clinical Pharmacy Annual Meeting, October 22nd, 2012 Hollywood, FL (poster presentation)
  • Moriarty PM, Gibson CA, Backes JM, Eldringhoff D, Powell S, Ruisinger JF. The effect of aggressive cardiovascular treatment on the progression of carotid intima-media thickness: Experience of an atherosclerosis prevention center. 79th European Atherosclerosis Society Congress Gothenburg, Sweden, June 26 - 29, 2011 (poster presentation)
  • “Good to Great” PGY1 Community Pharmacy Residency Programs Continuing Education Session invited CE program presented at the APhA Annual Meeting and Exposition, New Orleans, LA. March 11, 2012
  • “Interdisciplinary Research in a Clinical Setting: From Fruits to Nuts, alternative methods in treating atherosclerosis and dyslipidemia”. Internal Medicine Grand Rounds (CE). University of Kansas Medical Center. August 10th, 2011 (Co-presented with Patrick Moriarty, MD and Jim Backes, PharmD)
  • “Good to Great” PGY1 Community Pharmacy Residency Programs Continuing Education Session invited CE program presented at the APhA Annual Meeting and Exposition, Seattle, WA. March 27, 2011

Awards & Honors

  • APhA Distinguished Achievement Award in Pharmacy Practice (2013)
  • University of Kansas School of Pharmacy Preceptor of the Year (Chosen by the class of 2009)


  • American Pharmacists Association (APhA) Community Pharmacy Residency Program Advisory Panel (March 2011 – March 2014)
  • APhA Community Residency Accreditation Practitioner Reviewer (2008 – present)